Cognizance Market Research

Global Biologics Market to Reach US$985.61 Billion by 2032, Driven by Chronic Disease Rise and Biotech Innovations at 8.37% CAGR

Biologics are the biological drug product that is produced from living organism or contain components of living organisms. Biologic drugs include a wide variety of …

Read More

Cognizance Market Research

Global Amyotrophic Lateral Sclerosis Market to Reach US$1.11 Billion by 2030, Driven by Novel Therapies and Rising R&D Investment

Amyotrophic lateral sclerosis formerly known as Lou Gehrig’s disease, is a neurological disorder that affects motor neurons, the nerve cells in the brain and spinal …

Read More

Cognizance Market Research

Global Adrenoleukodystrophy Market Advances with New Therapeutic Developments and Increased Focus on Rare Genetic Disorders

Adrenoleukodystrophy (ALD) is a genetic condition in which group of neurological conditions known as leukodystrophies. Leukodystrophies are disorders that result from abnormalities in myelin, the …

Read More

Biologics Contract Manufacturing Market

Global Biologics Contract Manufacturing Market to Reach US$29.03 Billion by 2030, Driven by Rising Chronic Diseases and Outsourcing Trends

The market of biologics encompasses pharmaceuticals derived from living cells or organisms, including proteins, antibodies, and gene therapies. In contrast to conventional medications created through …

Read More

Electroporation Instruments

Global Electroporation Instruments Market to Reach US$288.9 Million by 2030, Driven by Rise in Chronic Diseases and Biotech R&D

The biotechnology, pharmaceutical, and contract research industries all primarily use electroporation technologies. It is applied in microbiology to modify prokaryotic cells by introducing artificial DNA …

Read More